SNYR (Synergy CHC) EPS without NRI: $-1.03 (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Synergy CHC EPS without NRI?

Synergy CHC SNYR +34.66% EPS without NRI is $-1.03 as of Mar. 2026. The stock has 3 warning signs investors should review. Among 101 Medical Distribution companies, Synergy CHC ranks worse than 93.07% on this metric.

Synergy CHC's earnings per share without non-recurring items for the three months ended in Mar. 2026 was $-0.23. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was $-1.03.

During the past 12 months, Synergy CHC's average earnings per share (NRI) Growth Rate was -430.60% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was -48.20% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 0.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Synergy CHC's EPS without NRI or its related term are showing as below:

SNYR' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -48.2   Med: -4.6   Max: 93.3
Current: -48.2

During the past 11 years, Synergy CHC's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 93.30% per year. The lowest was -48.20% per year. And the median was -4.60% per year.

SNYR's 3-Year EPS without NRI Growth Rate is ranked worse than
93.07% of 101 companies
in the Medical Distribution industry
Industry Median: 3.6 vs SNYR: -48.20

Synergy CHC's EPS (Diluted) for the three months ended in Mar. 2026 was $-0.23. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $-1.59.

Synergy CHC's EPS (Basic) for the three months ended in Mar. 2026 was $-0.23. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was $-1.59.


Synergy CHC  (NAS:SNYR) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Synergy CHC EPS without NRI Related Terms


Synergy CHC EPS without NRI Historical Data

* Premium members only.

The historical data trend for Synergy CHC's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Synergy CHC EPS without NRI Chart

Synergy CHC Annual Data
Trend Jul13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec23 Dec24 Dec25
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.71 -0.22 0.86 0.28 -0.73

Synergy CHC Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.10 -0.04 0.01 -0.76 -0.23

SNYR vs MEDS, MCK, COR: EPS without NRI Comparison

For the Medical Distribution subindustry, Synergy CHC's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Synergy CHC PE Ratio without NRI vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Synergy CHC's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Synergy CHC's PE Ratio without NRI falls into.



Synergy CHC EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of $-1.03 mean?
Synergy CHC (SNYR) has a EPS without NRI of $-1.03 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Synergy CHC and its competitors. According to the industry distribution chart, Synergy CHC ranks #94 out of 101 companies in the Medical Distribution industry, placing it in the top 93.1%.
Is Synergy CHC's EPS without NRI too high?
Synergy CHC's current EPS without NRI is $-1.03. Based on the distribution chart, Synergy CHC ranks #94 out of 101 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers.
How does Synergy CHC's EPS without NRI compare to MEDS and MCK?
According to the Medical Distribution industry distribution chart, Synergy CHC ranks #94 out of 101 companies for EPS without NRI. This places Synergy CHC in the lower half of its industry. The industry median EPS without NRI is 3.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Medical Distribution company?
The median EPS without NRI among Medical Distribution companies is 3.60, based on 101 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Synergy CHC and its competitors. For the Medical Distribution industry, the median EPS without NRI is 3.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Synergy CHC's current EPS without NRI is $-1.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synergy CHC stock overvalued right now?
Based on GuruFocus' analysis, Synergy CHC (SNYR) is currently considered Possible Value Trap. The stock's GF Value™ is $1.08, compared to a current price of $0.11 — trading 90% below its estimated fair value. The current EPS without NRI is $-1.03. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Synergy CHC (SNYR), the current EPS without NRI is $-1.03 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Synergy CHC Business Description

Address 1016, 770 Roosevelt Trail, Suite 8, North Windham, ME, USA, 04062
Synergy CHC Corp is a provider of consumer health care, beauty, and lifestyle products. It is engaged in the business of marketing and distributing consumer-branded products through various distribution channels in the health and wellness industry. The company's products include FOCUSfactor, Flat Tummy Tea, Hand MD, and Neuragen, amongst others. Flat Tummy is a lifestyle and wellness brand that provides a suite of nutritional products to help women achieve their nutrition and weight management goals.